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Abstract
Background: Widespread occupational exposure to carbon black nanoparticles (CBNPs) raises concerns over their
safety. CBNPs are genotoxic in vitro but less is known about their genotoxicity in various organs in vivo.
Methods: We investigated inflammatory and acute phase responses, DNA strand breaks (SB) and oxidatively
damaged DNA in C57BL/6 mice 1, 3 and 28 days after a single instillation of 0.018, 0.054 or 0.162 mg Printex 90
CBNPs, alongside sham controls. Bronchoalveolar lavage (BAL) fluid was analyzed for cellular composition. SB in
BAL cells, whole lung and liver were assessed using the alkaline comet assay. Formamidopyrimidine DNA
glycosylase (FPG) sensitive sites were assessed as an indicator of oxidatively damaged DNA. Pulmonary and hepatic
acute phase response was evaluated by Saa3 mRNA real-time quantitative PCR.
Results: Inflammation was strongest 1 and 3 days post-exposure, and remained elevated for the two highest
doses (i.e., 0.054 and 0.162 mg) 28 days post-exposure (P < 0.001). SB were detected in lung at all doses on post-
exposure day 1 (P < 0.001) and remained elevated at the two highest doses until day 28 (P < 0.05). BAL cell DNA
SB were elevated relative to controls at least at the highest dose on all post-exposure days (P < 0.05). The level of
FPG sensitive sites in lung was increased throughout with significant increases occurring on post-exposure days 1
and 3, in comparison to controls (P < 0.001-0.05). SB in liver were detected on post-exposure days 1 (P < 0.001)
and 28 (P < 0.001). Polymorphonuclear (PMN) cell counts in BAL correlated strongly with FPG sensitive sites in lung
(r = 0.88, P < 0.001), whereas no such correlation was observed with SB (r = 0.52, P = 0.08). CBNP increased the
expression of Saa3 mRNA in lung tissue on day 1 (all doses), 3 (all doses) and 28 (0.054 and 0.162 mg), but not in
liver.
Conclusions: Deposition of CBNPs in lung induces inflammatory and genotoxic effects in mouse lung that persist
considerably after the initial exposure. Our results demonstrate that CBNPs may cause genotoxicity both in the
primary exposed tissue, lung and BAL cells, and in a secondary tissue, the liver.
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Background
The use of nanoparticles (NPs) in consumer products
and applications continues to rise [1]. In parallel, the
potential for NP mediated toxicity is a growing public
concern. Many of the unique properties exhibited by
NPs increase the likelihood of deleterious biological
interactions and subsequently, the risk of adverse health
outcomes [2-4]. Understanding the repercussions of
inhaling NPs is particularly important because NPs
penetrate deeper regions of the lung (e.g., alveoli and
pulmonary interstitium) [5,6], are translocated from
lung to systemic circulation more readily [7,8], and are
cleared from the lungs less effectively [9] than their lar-
ger counterparts. As such, there is a great probability of
cellular interactions, necessitating investigations of NP-
mediated toxicity and risk of health consequences.
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its use as a benchmark control for in vivo toxicological
evaluation of diesel exhaust particles and as a model of
urban air pollution particulate matter almost three dec-
ades ago [10,11]. Since then, CB has become the focus
of numerous toxicity studies as well as an important
reference material (i.e., Printex 90) [12,13]. CBNPs are
reactive oxygen species (ROS) generators as shown in
cellular [14,15] and acellular systems [16]. Moreover,
inhalation or intratracheal instillation exposures to
CBNPs result in large pulmonary inflammatory
responses in rodents [17-24], which can greatly exacer-
bate ROS generation via activation of polymorphonuc-
lear (PMN) granulocytes [25]. As such, it is expected
that CBNPs can mediate secondary genotoxicity by
means of inflammation and oxidative stress. CBNPs are
genotoxic in vitro, as shown by increases in DNA base
oxidation [26], mutation frequency [26,27], strand
breaks [28,29] and micronucleus frequency in lung
epithelial cells [30] as well as increases in strand breaks
in fibroblasts [31]. However, less is known about the
genotoxicity of CBNPs in vivo.Af e ws t u d i e si nr a t s
have demonstrated CBNP-induced DNA base oxidation
[32] and increased mutation frequency [20]. However,
rats may not be the most suitable model for exposure to
particulates due to their predisposition to particle over-
load. Studies in mice have demonstrated DNA strand
breaks in BAL cells [21,33] and one study has estab-
lished CBNP-induced lung DNA strand breaks, but this
was found using a high dose (i.e., 0.2 mg) immediately
(3 hours) post instillation [30].
The growing demand for CBNPs for diverse commer-
cial applications (e.g., rubber products and pigments)
raises health concerns for the increasing number of indi-
viduals routinely exposed, especially in occupational set-
tings where relatively high levels of exposure may occur.
As such, it is critical to establish whether genotoxicity
and oxidative stress arise in vivo at low doses of expo-
sure and in extrapulmonary tissues, and to determine
whether these effects are associated with inflammation
and/or persist for long periods of time following the
initial exposure.
Here, we investigate the relationships between inflam-
mation and genotoxic outcomes over time after a single
exposure to Printex 90 CBNPs in BAL cells, lung and
liver. Mice were exposed via intratracheal instillation
using various doses (i.e., 0.018, 0.054 and 0.162 mg) and
post-exposure recovery time-points (i.e., 1, 3 and 28
days), alongside sham controls. We report that instilla-
tion of CBNPs leads to prolonged generation of DNA
damage in BAL cells, lung and liver of exposed mice as
well as persistent pulmonary inflammation, acute phase
response and oxidatively damaged DNA.
Results
Particle characterization
Printex 90 CBNPs were a gift from Evonik/Degussa
(Frankfurt, Germany). The manufacturer reported an
average primary particle size of 14 nm and an organic
impurity content of less than 1%. The specific surface
area was determined to be 295-338 m
2/g, corresponding
to a theoretical average spherical particle size of 8.1-9.5
nm [34]. The total carbon content measured was greater
than 99 wt%, with 0.82 nitrogen and 0.01 hydrogen wt%.
Very low levels of both total polycyclic aromatic hydro-
carbon (PAH) (74.2 ng/g) [26,27] and total endotoxin
(0.142 EU/mg Printex 90) were detected in the sample.
The particle suspension (the 0.054 mg dose) was charac-
terised by transmission electron microscopy (TEM) and
dynamic light scattering (DLS) analysis as previously
reported [34]. The TEM analysis of the instillation sus-
pension showed that the Printex 90 consisted of both
free and open to partially open chain-agglomerates (Fig-
ure 1A). The size of the primary carbon black spheres
was wide, ranging from less than 10 nm to more than
500 nm, whereas the agglomerate sizes typically were on
the order of 200 nm or larger. High-resolution analysis
showed that the spheres consisted of concentric layers
with graphitic spacing, resembling the nano-onions
structure.
By DLS, the unfiltered Printex 90 instillation suspen-
sion (which was employed for intratracheal instillation),
was shown to be highly agglomerated in the 10% BAL-
saline instillation medium. The propensity towards
agglomeration was in accordance with the low peak
zeta-potential of -10.7 mV determined for Printex 90 at
0.3 mg/ml instillation medium (conductivity 13.6 mS/
cm). The DLS size analysis of Printex 90 stock disper-
sion has been reported before [34]. Here, we present the
data in more detail (Figure 1A). The Printex 90 stock-
dispersion was highly agglomerated and had a very high
polydispersity index (PDI = 1). The hydrodynamic num-
ber size-distribution analysis showed a major peak at
approximately 2.6 μm (n = 4), almost comparable to the
peak-size (3.1 μm) in the volume-size-distribution. Fil-
tration was performed through a 3.0 and 0.2 μm filter to
investigate the possible presence of smaller particles,
which may not be detected by DLS due to the high
abundance of large agglomerates. Filtration through the
3.0 μm filter (n = 5) revealed the presence of smaller
particles with a number peak size of approximately 190
nm (220 nm by volume). Again the polydispersity index
was relatively high (PDI = 0.558) indicating a broad
size-distribution. This 190-220 nm size corresponds well
with the typical smaller free particle and agglomerate
sizes of the Printex 90 (Figure 2A). By filtration through
a0 . 2μmf i l t e rm o s to ft h ep a r t i c l e sw e r er e m o v e d
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weak, but consistent DLS signal was obtained on this
final filtrate. Repeated analyses showed consistent
results, but only one out of the first six analyses of the
same sample had acceptable data-quality for sizing. The
number size-distribution plot showed a highly dominant
size-mode with a primary peak-size at 7 nm. By volume,
a larger agglomerate mode was also found at 460 nm,
which can explain the relatively high polydispersity
index (PDI = 0.515) found in the 0.2 μm filtrate. The 7
nm size-mode obtained in the last filtrate could be due
to proteins in the dispersion vehicle (BAL fluid).
However, analysis of the pure instillation media did not
reveal any peak-sizes smaller than 20 nm (Figure 1B).
Therefore, the small size material found in the instilla-
tion medium is ascribed to a minor fraction of very
small Printex 90 particles, which were indeed observed
by TEM (Figure 2B). It should be noted that Printex 90
dispersed in MilliQ-filtered water results in much smal-
ler peak sizes of approximatly 50 to 60 nm [35].
BAL Fluid Cell Composition
We collected BAL fluid from Printex 90 CBNP instilled
mice using three doses (i.e., 0.018, 0.054 and 0.162 mg)
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Figure 1 Dynamic light scattering analysis of instillation medium: A) with 0.054 mg dose of Printex 90 CBNPs and B) instillation
medium alone (BAL + 10% saline).
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days). The inflammatory response was neutrophil domi-
nated and persisted 28 days post-exposure. The largest
cellular influxes were observed on post-exposure recov-
ery days 1 and 3 (Table 1).
Increased total cell counts in BAL fluid were found for
all doses and time-points, except for the lowest dose
delivered at the 28 day recovery time-point. The net
increase in the total number of cells relative to controls
i nt h eB A Lf l u i db yt h el a r g e s tC B N Pd o s ew a s1 . 5×
A  B 
Figure 2 Transmission electron microscopy images of CBNP particles in the instillation medium. A) Example of free and agglomerated
CBNP spheres of various sizes ranging from nano- to μm-size. Particles are caught on lacy-carbon Cu-grids. B) High-resolution image showing
the presence of 10 nm-size CB particles at the rim of a larger CB particle with mottled concentric layers with graphitic structure.
Table 1 BAL fluid cell counts and distribution of cells by type (%) in C57BL/6 mice 1, 3 and 28 days post-exposure to
0
Control 0.018 mg 0.054 mg 0.162 mg
24 h
Neutrophils x10
3 (%) 7.7 ± 1.7 (9.8) 65.0 ± 20.0 (44.3) ** 140.0 ± 28.0 (61.5) ** 160.0 ± 18.0 (73.9) **
Macrophages x10
3 (%) 53.0 ± 2.5 (73.1) 53.0 ± 6.8 (47.2) 50.0 ± 6.3 (31.4) 37.0 ± 5.8 (16.9) **
Eosinophils x10
3 (%) 0.3 ± 0.4 (0.3) 1.1 ± 0.4 (0.8) 3.1 ± 2.1 (1.3) 4.2 ± 2.6 (1.6)
Lymphocytes x10
3 (%) 1.5 ± 0.2 (2.2) 1.4 ± 0.6 (0.9) 2.5 ± 0.7 (1.3) 1.7 ± 0.9 (0.8)
Total BAL Cells x10
3 74.0 ± 3.6 130.0 ± 16.7 ** 200.0 ± 28.0 ** 220.0 ± 24.0 **
3 days
Neutrophils x10
3 (%) 3.0 ± 2.3 (2.4) 21.0 ± 5.9 (16.2) ** 63.0 ± 4.8 (40.5) ** 120.0 ± 13.0 (46.7) **
Macrophages x10
3 (%) 56.0 ± 4.2 (83.1) 86.0 ± 12.0 (65.8) * 63.0 ± 6.9 (40.3) 89.0 ± 12.0 (33.4) *
Eosinophils x10
3 (%) 0.4 ± 0.6 (0.6) 13.0 ± 5.8 (8.8) ** 16.0 ± 4.3 (10.4) ** 29.0 ± 9.9 (10.8) **
Lymphocytes x10
3 (%) 0.9 ± 0.2 (1.4) 3.8 ± 1.0 (2.9) ** 4.3 ± 1.0 (2.8) ** 8.4 ± 1.8 (3.3) **
Total BAL Cells x10
3 69.0 ± 6.4 130.0 ± 15.0 ** 160.0 ± 22.0 ** 270.0 ± 24.0 **
28 days
Neutrophils x10
3 (%) 1.2 ± 0.2 (1.2) 3.1 ± 0.5 (3.4) * 15.0 ± 3.1 (10.9) ** 50.0 ± 13.0 (29.3) **
Macrophages x10
3 (%) 82.0 ± 5.7 (85.6) 73.0 ± 9.4 (77.5) 99.0 ± 15.0 (73.3) 75.0 ± 4.3 (48.4)
Eosinophils x10
3 (%) 0.3 ± 0.0 (0.3) 3.4 ± 3.4 (2.8) 0.1 ± 0.1 (0.1) 0.1 ± 0.1 (0.1)
Lymphocytes x10
3 (%) 2.1 ± 0.4 (2.2) 3.5 ± 1.2 (4.1) 12.0 ± 2.7 (8.9) ** 22.0 ± 6.1 (13.4) **
Total BAL Cells x10
3 96.0 ± 5.8 93.0 ± 10.0 140.0 ± 21.0 ** 160.0 ± 16.0 **
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The increase in total BAL fluid cell counts was pri-
marily the result of large neutrophil influxes, which
were observed at all doses and time-points (Table 1).
The net influx of neutrophils relative to controls in the
BAL fluid following exposure to the highest dose of
Printex 90 was 1.5 × 10
5 cells (95% CI: 0.7 × 10
5-3.2 ×
10
5), 1.2 × 10
5 cells (95% CI: 0.8 × 10
5 -1 . 9×1 0
5)a n d
0.5 × 10
5 cells (95% CI: 0.3 × 10
5 -0 . 6×1 0
5)o np o s t -
exposure days 1, 3 and 28, respectively.
The number of macrophages decreased following
exposure to the highest dose of Printex 90 on post-
exposure day 1, but increased following low and high
dose Printex 90 exposures on post-exposure day 3
(Table 1). The number of lymphocytes increased 3 days
post-exposure for all three doses of Printex 90.
Increased numbers of lymphocytes were also observed
on post-exposure day 28 for both the medium and high
doses of Printex 90, thus suggesting onset of allergic air-
way inflammation. On post-exposure day 3, increased
eosinophils were observed for all doses, and an
increased number of epithelial cells was found at the
highest dose of Printex 90.
Acute phase response
Printex 90 increased the mRNA expression of Saa3 in
lung tissue on day 1 (all doses), 3 (all doses) and 28
(0.018 and 0.054 doses), whereas there were no effects
on the Saa3 mRNA expression in the liver (Table 2).
DNA Damage
We observed increased levels of SB in CBNP Printex 90
instilled mouse lung, liver and isolated BAL cells, rela-
tive to sham controls. SB in BAL cells were observed at
the high dose (i.e., 0.162 mg) for each time-point, as
well as at all doses 28 days post-exposure, relative to
controls (Figure 3). DNA SB, even 28 days after expo-
sure, were increased from 2.34 SB per 10
6 bp in the
control group to between 2.65-2.68 per 10
6 bp in the
exposed group (i.e., all doses). There was no apparent
dose-response relationship.
Increased SB were also observed in lung for all doses
relative to control, with the largest effects observed on
day 1. Levels of DNA SB 24 hours after the exposure
were greatly increased from 0.01 SB per 10
6 bp in the
control group, to between 0.08-0.09 SB per 10
6 bp in
the exposed group (i.e., all doses) (Figure 4A). Mice
exposed to the higher doses (i.e., 0.054 and 0.162 mg)
also exhibited elevated levels of SB 3 and 28 days post-
exposure relative to control animals.
The number of formamidopyrimidine DNA glycosy-
lase (FPG) sensitive sites in lungs (an indicator of oxida-
tive damage to DNA) was significantly elevated in all
dose groups of the CBNP exposed animals relative to
controls on day 1, with FPG sensitive sites of 0.22-0.37
per 10
6 bp in the exposed animals, compared to 0.10
per 10
6 bp in the controls (Figure 4B). Statistically sig-
nificant increases in FPG sensitive sites were also
observed for the high dose exposure (i.e., 0.162 mg) at
the 3 day recovery time-point. Marginal increases were
observed for the low dose groups on day 3 (i.e., 0.018
and 0.054 mg) and for the high dose groups on day 28
(i.e., 0.054 and 0.162 mg) in a dose-response trend.
DNA damage also occurred in liver of the CBNP
exposed mice with significantly elevated levels of SB on
days 1 and 28 (Figure 5), although not on day 3. Levels
of SB were increased from 1.61 lesions per 10
6 bp in the
control group, to 2.27-2.46 SB per 10
6 bp 24 hours
post-exposure and from 1.93 lesions per 10
6 bp in the
control group, to 2.10-2.34 SB per 10
6 bp 28 days post-
exposure. No apparent dose-response relationships were
observed in the liver.
In the lung, there was a strong correlation (r = 0.88, P
< 0.001) between FPG sensitive sites and BAL cell num-
bers across the doses and time points, whereas no such
correlations were observed between the number of BAL
cells and SB (r = 0.52, P = 0.08). The correlation
between the number of BAL cells and FPG sensitive
s i t e si nt h el u n gw a sm a i n l yd r i v e nb yt h ed i f f e r e n c e s
related to the doses and time points because the statisti-
cally significant association between BAL cell influxes
and FPG sensitive sites (r = 0.61, P < 0.001) vanished in
regression models adjusted for the effect of dose and
time-point.
Discussion
We investigated CBNP-mediated DNA damage and
inflammatory responses in Printex 90 instilled mice
using multiple doses (i.e., 0.018, 0.054 and 0.162 mg)
Table 2 Expression of Saa3 presented as fold-changes
over matched control in C57BL/6 mice 1, 3 and 28 days
post-exposure to 0
0.018 mg 0.054 mg 0.162 mg
Lung
24 h 63.7 ± 33.2 ** 240.3 ± 75.4 ** 298.2 ± 78.0 **
3 days 8.2 ± 4.2 ** 23.5 ± 6.7 ** 50.5 ± 14.6 **
28 days 1.1 ± 0.4 4.9 ± 2.2 ** 21.8 ± 10.1 **
Liver
24 h 1.2 ± 0.5 1.6 ± 0.5 1.3 ± 0.3
3 days 0.7 ± 0.2 0.7 ± 0.2 0.7 ± 0.2
28 days 1.0 ± 0.2 1.5 ± 0.2 1.3 ± 0.2
n = 6 except for the control groups
(n = 22)
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alongside sham controls. These doses equal the pulmon-
ary deposition after 1, 3 and 9 working days for a mouse
at the occupational exposure limit of 3.5 mg/m
3 CB per
8 hour work shift (as established by the Occupational
Safety and Health Administration (OSHA) and the
National Institute for Occupational Safety and Health
(NIOSH)). These calculations assume that 33.8% of the
inhaled mass ends up in the pulmonary region [33] with
a volume of inhaled air per hour of 1.8 L/h [36] and 8 h
working days. CB exposure levels of up to 3.7 mg/m
3,
2.2 mg/m
3 and 4.2 mg/m
3 have been reported for work-
ers implicated in packaging and in handling CB [37-39].
BAL cell influxes revealed CBNP-induced inflammation
that peaked 1 and 3 days post-exposure and persisted
28 days thereafter (Table 1). SB were detected in lung
and liver tissues and isolated BAL cells relative to con-
trols and persisted to day 28 (Figures 3, 4A and 5). FPG
sensitive sites in lung were increased throughout with
significant increases occurring on post-exposure days 1
and 3 in comparison to controls (Figure 4B). The
expression of Saa3 mRNA in lung tissue was increased
at all time-points. This reflects a persistent acute phase
response during the entire experiment (Table 2). The
correlation between total BAL cells and FPG sensitive
sites across all doses and time-points suggests an impor-
tant role for BAL cell influxes in generation of oxidative
stress in the lungs. This study is the first to demonstrate
in vivo low dose CBNP-induced SB in lung and liver,
which persist 28 days after a single exposure.
Although the primary particle size of Printex 90 (as
dry powder) was stated by the supplier to be 14 nm,
CBNP suspensions were shown to be highly agglomer-
ated by DLS. When analyzing the unfiltered suspension
we were only able to detect particles with a peak size of
2.6 μm. However, this is an artefact of the DLS metho-
dology in which larger agglomerated particles will over-
shadow smaller particles. Consequently, DLS on
unfiltered samples can only detect the largest particles
in the suspension. Therefore, we filtered the suspension
to remove the largest particles in order to be able to
detect the smaller particles. DLS on the filtered suspen-
sion confirmed the presence of smaller particles as well
(peak size of 190 nm and range of 90-350 nm). This
shows that some of the particles in the suspension used
for instillation are nano-sized, but the DLS analysis is
unable to quantify the proportion of nano-sized particles
in the suspension.
As in other studies of NP toxicity, endotoxin present
on the NPs can result in inflammatory responses. How-
ever, the very low level of endotoxin detected on the
CBNPs (0.142 EU/mg CBNP) is not anticipated to result
in any significant inflammatory response. In another
study, the response of LPS instillation was investigated
in mice [40]. Instillation of a high dose of LPS (100 μg
= 1200 000 EU) resulted in a high inflammatory
response, while a low dose of LPS (0.1 μg = 1200 EU)
resulted in a low inflammatory response. We have
instilled doses ranging from 0.003 EU (0.142 EU/mg ×
0.018 mg) to 0.02 EU (0.142 EU/mg × 0.162 mg). The
Figure 3 DNA strand breaks (SB) per 10
6 base pairs in C57BL/6 mouse BAL cells following exposure to 0.000, 0.018, 0.054 or 0.162
mg Printex 90 CBNPs and sacrificed 1, 3, and 28 days post-exposure. Error bars represent the standard error of the mean for 6 mice in
each group. *, ** refers to a statistical significance of P < 0.05 and P < 0.001 respectively, when compared by two-factor ANOVA using the day
of sacrifice and dose as categorical variables.
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Page 6 of 14Figure 4 DNA strand breaks (SB) and formamidopyrimidine DNA glycosylase (FPG) sensitive sites in lung of CBNP exposed mice.S B
(A) and FPG sensitive sites (B) per 10
6 base pairs in C57BL/6 mouse lung tissue following exposure to 0.000, 0.018, 0.054 or 0.162 mg Printex 90
CBNPs and sacrificed 1, 3, and 28 days post-exposure. Error bars represent the standard error of the mean for 6 mice in each group. *, ** refers
to a statistical significance of P < 0.05 and P < 0.001 respectively, when compared by two-factor ANOVA using the day of sacrifice and dose as
categorical variables.
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are therefore several orders of magnitude below what is
considered a low dose of LPS, and thus are expected to
result in very little (if any) endotoxin induced
inflammation.
SB in lung and BAL cells demonstrate CBNP-induced
DNA damage at the site of exposure (Figures 3 and 4A).
Although CBNP-induced DNA SB have been investi-
gated in vitro [30,31,33,34], only one study has investi-
gated SB in mouse lung in vivo,a n dt h i sw o r ku s e da
single high dose (i.e., 0.2 mg instillation) [30]. In con-
trast, we demonstrate that SB in lung occur at much
lower doses of exposure (e.g., as low as 0.018 mg). Our
BAL findings corroborate two earlier studies demon-
strating CBNP-induced SB in C57BL/6 and tumour
necrosis factor (TNF) deficient mice exposed by inhala-
tion (i.e., 20 mg/m
3, 90 min/day, 4 days) [21], and apoli-
poprotein E (ApoE) deficient and C57BL/6 mice
exposed by instillation (i.e., 0.054 mg) [33]. Thus, our
results indicate that SB result from exposure levels that
are much lower than previously reported.
The aforementioned in vivo works investigated pul-
monary and BAL SB shortly after CBNP exposure, using
recovery time-points ranging from 1 to 24 hours
[21,30,33]. Taking into consideration that SB are readily
repaired within a few hours of induction [41], we aimed
to establish whether de novo DNA SB could be induced
at much later post-exposure time-points (e.g., 3 and 28
days). Interestingly, we observed SB at all post-exposure
time-points for the mice exposed to the high dose
relative to controls in both lung and BAL cells, and
these effects often extended to lower dose groups (Fig-
ures 3 and 4A). As such, we demonstrate that CBNPs
can generate pulmonary and BAL SB even 28 days after
a single exposure. In addition, we demonstrate that
assessing SB in cells may serve as a potential biomarker
of pulmonary genotoxicity in human studies.
Several mechanisms are hypothesized to contribute
to CBNP-induced genotoxicity. It has been suggested
that CB may be genotoxic because of adsorbed surface
compounds, primarily polycyclic aromatic hydrocar-
bons (PAHs). However, because of the low levels of
PAHs found on the CBNP surface (e.g., 72.4 ng/g in
the Printex 90 used in this work) and the high affinity
of these compounds for the CB particle core, CBNP-
induced toxicity is not likely mediated via PAH expo-
sure [26,27,42]. Alternatively, CBNPs have been identi-
fied as potent ROS generators [14-16] and are also
associated with large inflammatory responses, as estab-
lished by our BAL cell profiles and by the work of
others [17-24]. Pulmonary influxes in BAL cells induce
ROS production at sites of acute inflammation as a
result of degranulation and oxidative burst mechan-
isms [43]. More importantly, the mutation spectrum
arising in vitro following CBNP exposure points to
ROS as the primary mutagenic factor [27], providing
substantial evidence that ROS-induced DNA damage
occurs upon CBNP exposure. As such, we speculate
that oxidative stress could be an important parameter
of toxicity requiring further investigation in vivo.
Figure 5 DNA strand breaks (SB) per 10
6 base pairs in C57BL/6 mouse liver following exposure to 0.000, 0.018, 0.054 or 0.162 mg
Printex 90 CBNPs and sacrificed 1, 3, and 28 days post-exposure. Error bars represent the standard error of the mean for 6 mice in each
group. *, ** refers to a statistical significance of P < 0.05 and P < 0.001 respectively, when compared by two-factor ANOVA using the day of
sacrifice and dose as categorical variables.
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leads to increased mutation frequencies, and there is
increasing evidence for a direct association between
levels of oxidatively damaged guanine lesions and
increased risks of lung cancer in humans [44,45]. In
contrast to BAL cells that are generated from hemato-
poietic stem cells, mutations in lung can result in per-
manent genetic changes within tissue and therefore
increased cancer risk. As such, we examined lung tissue
directly for oxidative damage to DNA. FPG sensitive
sites were quantified using the alkaline comet assay, by
which oxidized purines, primarily 8-oxo-7, 8-dihydro-2’-
deoxyguanosine (8-oxodG) and 2, 6-diamino-4-hydroxy-
5-formamidopyrimidine are recognized. 8-oxodG is the
most commonly oxidized lesion and is pro-mutagenic
due to its ability to base-pair with adenine, resulting in
G to T transversions [46]. Previous in vitro work has
revealed non-significant increases in the levels of FPG
sensitive sites in human Caco-2 cells exposed to CB (20
μg/cm
2, 4 h exposure) [47], whereas significant increases
in FPG sensitive sites were found in an immortalized
Muta™Mouse lung epithelial cell line (11.3 μg/cm
2 or
75 μg/ml, 3 h exposure) [26]. Here, we demonstrate that
CBNPs induce FPG sensitive sites in vivo in the lungs.
This is consistent with a previous inhalation study in
rats where an elevated dose of Printex 90 (i.e. more
than 5 mg retained in the lungs) caused increased 8-
oxodG, which persisted for 44 weeks [32]. No effects
were observed for lower doses. Considering differences
between species (e.g., approximate weights of 20 and
200 g and pulmonary surface area of 82.2 and 300 cm
2
in mouse and rat respectively [48,49]) this 5 mg retained
dose in our model would translate to instilled doses of
0 . 5m go r1 . 4m ga c c o r d i n gt ob o d yw e i g h ta n dl u n g
surface area, which is well above our highest exposure
dose. However, levels of 8-oxodG can often be elevated
by spurious oxidation [50] and thus it is possible that
effects may have been detected at lower dose levels with
lower background levels. A high dose (i.e., 0.050 mg ×
6) of Printex 90 repeated six times in six weeks also
caused increased immunostaining for 8-oxodG in the
lungs of mice [51]. Thus, in the present study we
observed increased FPG sensitive sites at much lower
CBNP doses (i.e., 0.018 and 0.054 mg) and at later post-
exposure recovery time-points relative to previous stu-
dies, with significant increases occurring on post-expo-
sure days 1 and 3 (Figure 4B).
T h ei n c r e a s ei np o s s i b l eo x i d a t i v e l yd a m a g e dD N A
observed in our study in comparison to controls was
much higher than previous in vitro observations. For
example, [26] showed a less than two fold increase over
controls in lung epithelial cells, following 3 h of expo-
sure to 75 μg/ml CBNPs (a dose of approximately 11.3
μg/cm
2 cells compared to 0.2-2.0 μg/cm
2 in the current
work [48]). This might be because of the presence of
ROS-producing granulocytes in the mouse lung, as indi-
cated by the close correlation of PMN cells and FPG
sensitive sites found. In keeping with this observation,
rats exposed by intratracheal administration of 0.64 mg/
kg body weight (i.e., our low dose is approximately 0.9
mg/kg body weight in mouse), developed neither inflam-
mation in terms of PMN infiltration nor increased levels
of 8-oxodG in lung parenchyma [52]. We speculate that
the pulmonary genotoxocity observed in our work is
most likely related to oxidative stress mediated by
inflammatory cells, which is in accordance with previous
work that has shown CBNP-induced mutation frequency
increases only after inflammation is established [20]. On
the other hand, we have previously found that SB and
pro-inflammatory effects occurred independently of
each other in vitro [53] and in BAL cells in vivo
[21,34,54,55]. In the present study, inflammation and
BAL cell SB were observed at all doses and time points,
and thus, we are not able to determine if the observed
SB are caused by inflammation or whether inflammation
and genotoxicity occur independently of each other.
Large inflammatory responses, such as the ones
observed in our work, are associated with systemic
effects of exposure due to increases in circulating
inflammatory cells (e.g., PMN) and molecular mediators
of inflammation (e.g., pro-inflammatory cytokines and
chemokines). Additionally, NPs themselves have been
demonstrated to translocate into systemic circulation
[56] and spark generated ultrafine carbon NPs have
been shown to accumulate in liver of rats upon inhala-
tion [8]. Likewise, individual exposure to traffic related
air pollution at the home address and by occupation has
been associated with an increased risk of hepatic cancer
[57,58]. In order to investigate the possibility of adverse
effects in extra-pulmonary tissues, we used the alkaline
comet assay to quantify SB in liver tissue of the same
mice. We found that SB were elevated on post-exposure
days 1 and 28 (Figure 5). The reason for the lack of
damage on day 3 remains unclear. It is possible that two
separate mechanisms may come into play at different
times (e.g., direct instillation effects on day 1 vs. particle
relocation to liver or persistent inflammation on day
28), thus not affecting this post-exposure time-point.
The results on particle-induced hepatic DNA damage
are consistent with our recently published study on
D N Ad a m a g ei nm i c ee x p o s e dt oP r i n t e x9 0b yi n h a l a -
tion [35]. Two different mechanisms are hypothesized to
be responsible for the observed hepatic DNA damage: 1)
direct particle-mediated effect caused by particles trans-
located from the lungs to the systemic circulation, and
2) indirect effects related to systemic inflammation. To
investigate if the hepatic DNA damage resulted from a
systemic acute phase response, we measured the mRNA
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we reported before with mice exposed to CB or diesel
exhaust particles by inhalation [59], we did not detect a
change in Saa3 mRNA in the liver in the current study.
In contrast, we found a large increase in pulmonary
Saa3 mRNA expression. SAA protein can be detected in
circulation during pulmonary inflammation and may
induce a systemic acute phase response [60]. We have
recently reported that the acute phase response is also
induced in the lungs of mice exposed to nanotitanium
dioxide where increased levels of SAA protein was also
detected in lung tissue [61]. We do not know whether
the hepatic effects are caused by inflammation or direct
effects of translocated particles, but since translocation
of the CBNPs is expected to be low, and particles accu-
mulate primarily in Kupffer cells in the liver [62], the
observed hepatic effects are most likely caused by
inflammation. To our knowledge, our work is the first
to demonstrate that hepatic SB occur as a result of
exposure to CBNPs via intratracheal instillation.
There is increasing evidence that both DNA SB and
oxidative damage to DNA can lead to increased risk of
tumorigenesis and carcinogenesis [63-66]. Likewise, the
relationship linking chronic inflammation to increase
risk of carcinogenic outcome is increasingly well sup-
ported [67]. As such, it is likely that regular exposure to
CBNPs is involved in adverse health outcomes that
include cancer. Although previous epidemiological data
have linked CBNP exposures to pulmonary carcinogen-
esis [68-70], evidence to date is insufficient to classify
these particles as human carcinogens (currently classi-
fied as possibly carcinogenic to humans under Group
2B) [71]. As such, further investigations should elucidate
additional underlying mechanisms of toxicity induced by
CBNPs and their relationship with disease development.
This should include simultaneous investigations of oxi-
dative stress, genotoxicicty and inflammation in lung
and liver of exposed mice using multiple endpoints (e.g.,
micronucleus assay, mutation analysis and GSH levels)
and in repeated chronic daily inhalation studies to more
closely mimic human exposures. Furthermore, as effects
were observed at lower doses of exposure, dose-response
relationships should be examined to establish the lowest
observable effects and no observable effects levels. In
addition to mechanistic studies, future works should
clearly establish current human exposure levels in order
to evaluate the risks of adverse health effects in indivi-
duals routinely exposed to CBNPs.
Conclusion
CBNP exposed mice exhibited increased DNA SB and
inflammation at exposure doses as low as 0.018 mg and
as much as 28 days following a single exposure in BAL
cells, lung and liver tissue. Oxidative stress conditions
were suggested by the presence of FPG-sensitive sites in
DNA. The data suggest that these related mechanisms
(e.g., inflammation and DNA damage) can interact and
possibly contribute to carcinogenic outcomes, potentially
at lower doses than suggested previously.
Materials and methods
Animals
Female C57BL/6 mice aged 5-6 weeks were obtained
from Taconic (Ry, Denmark). Mice were acclimatized
for 2-3 weeks before the experiment and were 8 weeks
of age at the start of the study. All mice were given food
(Altromin no. 1324, Christian Petersen, Denmark) and
water ad libitum. The mice were group housed in poly-
propylene cages with sawdust bedding at controlled
temperature (21 ± 1°C) and humidity (50 ± 10%) with a
12-h light:12-h dark cycle. The experiments were
approved by the Danish “Animal Experiments Inspecto-
rate” (permit 2010/561-1179) and carried out following
their guidelines for ethical conduct and care when using
animals in research. All procedures complied with EC
Directive 86/609/EEC and Danish laws regulating
experiments on animals.
Preparation of exposure stock
Printex 90 was suspended by sonication in 0.9% NaCl
MilliQ water containing 10% v/v acellular BAL from
C57BL/6 mice. The BAL fluid was prepared by flushing
unexposed mice twice with 0 . 6m l0 . 9 %N a C ls o l u t i o n
yielding approximately 1 ml of BAL fluid. Acellular BAL
was prepared by centrifugation of BAL fluid at 400 g
(10 min, 4°C). The particle suspensions (4.05 mg/ml)
were sonicated using a 400 W Branson Sonifier S-450D
(Branson Ultrasonics Corp., Danbury, CT, USA)
equipped with a disruptor horn (Model number: 101-
147-037). Total sonication time was 8 min, with alter-
nating 10 s pulses and 10 s pauses at amplitude of 10%.
S a m p l e sw e r ec o n t i n u o u s l yc o o l e do ni c ed u r i n gt h e
sonication procedure. This suspension was used for the
high dose, diluted 1:3 for the medium dose (0.054 mg)
and diluted further 1:3 for the low dose (0.018 mg).
Vehicle control solutions were prepared containing 90%
0.9% NaCl MilliQ water and 10% acellular BAL fluid.
Characterization of exposure
The hydrodynamic particle size distributions in the
exposure media were determined by Dynamic Light
Scattering (DLS) using a Malvern Zetasizer Nano ZS
(Malvern Instruments Ltd, UK). Data were analyzed
using the Dispersion Technology Software (DTS) ver-
sion 5.0 (Malvern Instruments Ltd). Samples were mea-
sured at 25°C in 1 mL Malvern disposable polystyrene
cuvettes. For analysis of hydrodynamic size, we used the
refractive (Ri) and absorption indices (Rabs) of 2.020 and
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and viscosity properties for H2O. For analysis of the
instillation medium we used the Malvern standard con-
ditions for both water and protein (Ri = 1.450; Rabs =
0.001). The nature of particles and level of agglomera-
tion was also evaluated by TEM using a 200 kV Tecnai
T20 G2 Transmission Electron Microscope at the DTU
Center for Electron Nanoscopy, Technical University of
Denmark, Lyngby. DLS analysis of exposure media was
performed on the raw instillation dispersions and after
filtration through 3 μm (Glass Micro Fiber;Whatmann,
UK) and 0.2 μm (hydrophilic DISMIC
®-25CS Cellulose
Acetate; Toyo Roshi Kaisha Ltd, Japan) syringe filters.
Zeta-potential measurements were completed using
instillation mediums with a Printex 90 concentration of
0.3 mg/ml according to the Smoulowkowski model and
using Malvern’s folded capillary cuvettes DTS1060 in
the general purpose mode using the Malvern Zetasizer
above. All data were obtained based on six consecutively
repeated analyses of the same sample with no pause.
Acceptance of the size-distribution data was done after
evaluation of the correlation spectra and size-distribu-
tion fit and standard quality reports in the software. The
quality of the zeta-potential measurements was con-
trolled by evaluation of counts, sample conductivity,
phase-plots, as well as zeta- and mobility data. In all
cases, outliers identified following quality control were
removed from the final average value.
Exposure of mice
A total of 72 mice (6 per group) were given 0.018, 0.054
or 0.162 mg of Printex 90 CBNPs by a single intratra-
cheal instillation. Before the intratracheal instillation, the
mice were anesthetized using Hypnorm
® (fentanyl
citrate 0.315 mg/ml and fluanisone 10 mg/ml from Jans-
sen Pharma) and Dormicum
® (Midazolam 5 mg/mL
from Roche). Both anaesthetics were mixed with equal
volumes sterile water. A volume of 0.15 ml was injected
subcutaneously in the neck of each mouse. The sedated
mice were kept on 37°C heating plates. During instilla-
tion the mice were placed on their backs on a 40 degree
slope. The trachea was intubated using a 24 gauge BD
Insyte catheter (Becton Dickinson, Denmark) with a
shortened needle. The correct location of each intuba-
tion was tested using a highly sensitive pressure trans-
ducer (pneutachymeter) developed at the National
Research Centre for the Working Environment in colla-
boration with John Frederiksen (FFE/P, Copenhagen,
Denmark). A 40 μl suspension was instilled followed by
150 μl air with a 250 μl SGE glass syringe (250F-LT-GT,
MicroLab, Aarhus, Denmark). Control animals received
vehicle instillations. The intubation catheter was held
head up until proper breathing was assured. The mice
were then transferred to the 37°C heating plate until
they recovered from anaesthesia. The animals did not
show signs of respiratory distress, lethargy or other phy-
sical symptoms of exposure.
Preparation of tissue and cells from the mice
One, 3 and 28 days after the instillation, the mice were
anaesthetised with Hypnorm/Dormicum as described
above. Immediately after withdrawing the heart blood, a
bronchoalveolar lavage (BAL) was performed four times
w i t h0 . 8m Lo f0 . 9 %s t e r i l es a l i n et h r o u g ht h et r a c h e a .
The BAL was immediately put on ice until BAL fluid
and BAL cells were separated by centrifugation at 4°C
and 400 g for 10 min. The BAL cells were resuspended
in 100 μL medium (HAMF12 with 10% fetal bovine
serum). The suspension (40 μL) was mixed with 160 μL
medium containing 10% DMSO and stored at -80°C for
later analysis in the comet assay. For differential count,
cells from 50 μL were collected on microscope slides by
centrifugation at 10, 000 rpm for 4 min in a Cytofuge 2
(StatSpin, Bie and Berntsen, Rødovre, Denmark). The
slides were fixed with 96% ethanol and stained with
May-Grünwald-Giemsa stain. The cellular composition
of BAL cells was determined on 200 cells. The total
number of cells was determined by using the Nucleo-
Counter (Chemometec, Allerød, Denmark) live/dead
assay according to the manufacturer’si n s t r u c t i o n s .T h e
lungs and liver were snap frozen in cryotubes (NUNC)
in liquid N2 and stored at -80°C.
DNA Damage measured by the Comet Assay
W h o l el u n ga n dl i v e rw e r eb r o k e ni n t os p e c i f i cp i e c e s
under liquid nitrogen, homogenized in Merchant’s
EDTA (0.14 M NaCl, 1.47 mM KH2PO4,2 . 7m MK C l ,
8.1 mM Na2HPO4, 10 mM EDTA) and filtered at 70
μm to yield individual cells. Two different comet meth-
ods were used to process the BAL cells/liver tissue and
the lung tissue samples.
DNA SB in liver and BAL cells were analyzed using a
high throughput protocol allowing 48 samples per Gel-
Bond
® film, developed at the Norwegian Institute of
Public Health (Gunnar Brunborg and Kristine Bjerve
Gutzkow) within the COMICS EU Project as previously
described [35]. The BAL cells were quickly thawed in a
37°C waterbath before being mixed with agarose. The
freezing and thawing of the cells was validated not to
have any effect on experimental outcome in a cell line
and in primary lymphocytes with correlation coefficients
(r) of 0.96-0.99. In the present experiment, the cell/agar-
ose suspension was applied onto a GelBond
(R) film (7
μL per sample) with a multichannel pipette. Eight films
were processed per electrophoresis, in two parallel elec-
trophoresis tanks. Due to preparation time, the lysing
procedure varied between 1-2 hours for samples in the
present study (up to 3.5 hours). The high volume
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one film and reduced the variation caused by increased
processing time and different electrophoreses.
The slides were inspected using a Leica LB fluores-
cence microscope at 400 × magnification with a 450-
490 nm emission filter and an LP515 excitation filter.
DNA damage was measured as comet tail length (TL)
using the Kinetics image analysing system (version 3.0).
To eliminate day-to-day variation, the data were nor-
malized to the level in A549 cells included on each
electrophoresis gel. The mean TL ± SEM (μm) for the 0
and 30 μMH 2O2 exposed A549 cells were 45.85 ± 4.49
and 73.27 ± 3.14 for analysis of the liver samples and
45.13 ± 2.59 and 71.92 ± 3.13 for the analysis of the
BAL cells.
DNA SB in whole lung were measured as the forma-
tion of SB and FPG sensitive sites as previously
described [72]. The level of FPG sensitive sites was cal-
culated as the differences in DNA damage between
slides that had been treated with the FPG enzyme and
buffer. The FPG enzyme was a gift from Professor
Andrew Collins (University of Oslo, Norway). Scoring
was accomplished by visual inspection of 100 nuclei and
categorized using a five class scoring system (ranging
from 0-400). The five class scoring system shows excel-
lent correlation with computerised image analysis of the
DNA migration [73]. We used this calibration of the
comet assay endpoint because this provides better inter-
investigator accuracy [74,75] and reduces the inter-
laboratory variation in reported values of DNA damage
by the comet assay [76-78]. The data were transformed
into lesions/10
6 bp using a previously established
gamma irradiation calibration curve [76]. All samples
were coded prior to scoring and organized to block the
effects of day of experiments. We used human lympho-
cytes, treated with 1 μM Ro19-8022 photosensitizer and
UV-light as control samples as described previously
[79]. This treatment generates predominantly FPG sensi-
tive sites as compared to SB. The Ro19-8022 photosen-
sitizer was a gift from F. Hoffman, La Roche, Basel,
Switzerland. The mean lesion per bp ± SEM were in
these reference control samples were 0.068 ± 0.002 SB/
10
6 bp and 2.045 ± 0.002 FPG sensitive site/10
6 bp.
Saa3 mRNA expression
RNA was prepared using the NucleoSpin 96 RNA kit
(Macherey-Nagel, Germany). RNA from the entire left
lung of each mouse or a piece of liver tissue was pre-
pared by lysing the tissue in 2 ml RLT buffer, while vig-
orously disrupting the sample with a Tissuelyser
(Qiagen, Denmark) with a 5 mm stainless steel bead for
2 × 60 seconds and run through a QIAshredder (Qia-
gen, USA). The rest of the purification was performed
as described by the manufacturer. cDNA was prepared
using TaqMan reverse transcription reagents (Applied
Biosystems, USA) as described by manufacturer.
Saa3 mRNA expression levels were determined as
described previously [59].
Statistics
The data on DNA damage, Saa3 mRNA expression and
total number of cells in BAL fluid were analysed using a
two-factor ANOVA analysis with the day of sacrifice
and dose as categorical variables. We assessed differ-
ences in the BAL fluid cell composition using a one-fac-
tor ANOVA for each day of sacrifice, as well as by non-
parametric Kruskal-Wallis or Mann-Whitney tests. The
same significant effects were found in both parametric
and non-parametric tests. The results on the number of
cellular subsets of the BAL fluid were analyzed as log-
transformed for macrophages and epithelial cells. Some
samples of BAL fluid did not contain neutrophils, lym-
phocytes and eosinophils; we added the mean level of
cells from the control group to all results to avoid pro-
blems with log-transformation of zero. Associations
between the level of PMN and FPG sensitive sites in
lung tissue were assessed by linear regression analysis
with or without adjustment for effect of dose and time
point. In all tests, the level of significance was 5%. The
analyses were performed in Statistica version 5.5 for
Windows (StatSoft Inc. (1997), USA).
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